{"id":"placebo-for-vitamin-b-compound","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108015","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to measure the effect of an active drug against baseline or psychological expectation. In this case, it serves as a comparator arm in a Phase 3 trial evaluating a Vitamin B compound, allowing researchers to distinguish true drug efficacy from placebo response.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:28.045Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 trial for Vitamin B compound (specific indication unknown)"}]},"trialDetails":[{"nctId":"NCT07348328","phase":"NA","title":"Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-02-01","conditions":"Cardiovascular Surgical Procedures, Major Adverse Cardiovascular Events (MACE)","enrollment":1000},{"nctId":"NCT05638633","phase":"PHASE3","title":"Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome","status":"COMPLETED","sponsor":"Wuerzburg University Hospital","startDate":"2022-11-11","conditions":"Post-COVID-19 Syndrome","enrollment":321},{"nctId":"NCT06444243","phase":"PHASE2","title":"Psilocybin-assisted Therapy for Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"University of Sydney","startDate":"2024-09","conditions":"Alcohol Use Disorder, Alcohol Dependence, Depression","enrollment":90},{"nctId":"NCT06363565","phase":"NA","title":"Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-06-01","conditions":"Homocysteine","enrollment":220},{"nctId":"NCT01022229","phase":"PHASE3","title":"The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2013-11","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["N.I."],"phase":"phase_3","status":"active","brandName":"Placebo for Vitamin B compound","genericName":"Placebo for Vitamin B compound","companyName":"Wuerzburg University Hospital","companyId":"wuerzburg-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in Phase 3 trial for Vitamin B compound (specific indication unknown).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}